Discover critical updates from Conduit Pharmaceuticals Inc. in its 8-K filing. Get insights on common stock, redeemable warrants, and financial implications as of February 12, 2025.
Explore Conduit Pharmaceuticals Inc.'s 8-K filing from February 7, 2025, detailing common stock, redeemable warrants, and trading symbols CDT and CDTTW on NASDAQ.
Explore Conduit Pharmaceuticals Inc.'s latest 8-K report from January 13, 2025, detailing stock, warrants, and financial strategies. Essential for investors and analysts.
Explore Conduit Pharmaceuticals Inc.'s stock details as of December 17, 2024, including par value, ticker symbols, and redeemable warrants. Essential info for investors.
Explore Conduit Pharmaceuticals Inc.'s 8-K report from December 12, 2024, detailing stock performance, financial metrics, and essential updates for investors and stakeholders.